Journal Article: Potential of β2AR for added benefit in treating heart failure through a better understanding of signaling
Walweel, Kafa, Cheesman, Elizabeth and Molenaar, Peter (2023). Potential of β2AR for added benefit in treating heart failure through a better understanding of signaling. Current Opinion in Physiology, 36 100719, 100719. doi: 10.1016/j.cophys.2023.100719
Journal Article: Donor heart ischemic time can be extended to 8 hours using hypothermic machine perfusion in sheep
See Hoe, Louise E., Bassi, Gianluigi Li, Wildi, Karin, Passmore, Margaret R., Bouquet, Mahe, Sato, Kei, Heinsar, Silver, Ainola, Carmen, Bartnikowski, Nicole, Wilson, Emily S., Hyslop, Kieran, Skeggs, Kris, Obonyo, Nchafatso G., Shuker, Tristan, Bradbury, Lucy, Palmieri, Chiara, Pedersen, Sanne-Engkilde, McDonald, Charles, Colombo, Sebastiano M., Wells, Matthew A., Reid, Janice D., O'Neill, Hollier, Livingstone, Samantha, Abbate, Gabriella, Haymet, Andrew, Jung, Jae-Seung, Sato, Noriko, James, Lynnette, He, Ting ... Fraser, John F. (2023). Donor heart ischemic time can be extended to 8 hours using hypothermic machine perfusion in sheep. The Journal of Heart and Lung Transplantation, 42 (8), 1015-1029. doi: 10.1016/j.healun.2023.03.020
Aminu, Abimbola J., Chen, Weixuan, Yin, Zeyuan, Kuniewicz, Marcin, Walocha, Jerzy, Perde, Filip, Molenaar, Peter, Iaizzo, Paul A., Dobrzynski, Halina and Atkinson, Andrew J. (2022). Novel micro-computed tomography contrast agents to visualise the human cardiac conduction system and surrounding structures in hearts from normal, aged, and obese individuals: Iodine and graphene oxide – visualising human conduction system in normal, aged, and obese hearts. Translational Research in Anatomy, 27 100175, 1-17. doi: 10.1016/j.tria.2022.100175
(2023–2028) Research Donation Generic
(2023–2026) Prince Charles Hospital Foundation
Determination of effects of Atrogi compounds in human heart
(2022–2023) Atrogi AB
Cause and prevention of stress induced arrhythmias in human heart
Doctor Philosophy
The Genetic Basis of Carvedilol Responsiveness in Human Heart Failure
(2008) Master Philosophy
FACTORS CONTRIBUTING TO THE DEVELOPMENT OF CARDIAC HYPERTROPHY - CALCINEURIN DEPENDENT PATHWAY
(2006) Doctor Philosophy
Walweel, Kafa, Cheesman, Elizabeth and Molenaar, Peter (2023). Potential of β2AR for added benefit in treating heart failure through a better understanding of signaling. Current Opinion in Physiology, 36 100719, 100719. doi: 10.1016/j.cophys.2023.100719
Donor heart ischemic time can be extended to 8 hours using hypothermic machine perfusion in sheep
See Hoe, Louise E., Bassi, Gianluigi Li, Wildi, Karin, Passmore, Margaret R., Bouquet, Mahe, Sato, Kei, Heinsar, Silver, Ainola, Carmen, Bartnikowski, Nicole, Wilson, Emily S., Hyslop, Kieran, Skeggs, Kris, Obonyo, Nchafatso G., Shuker, Tristan, Bradbury, Lucy, Palmieri, Chiara, Pedersen, Sanne-Engkilde, McDonald, Charles, Colombo, Sebastiano M., Wells, Matthew A., Reid, Janice D., O'Neill, Hollier, Livingstone, Samantha, Abbate, Gabriella, Haymet, Andrew, Jung, Jae-Seung, Sato, Noriko, James, Lynnette, He, Ting ... Fraser, John F. (2023). Donor heart ischemic time can be extended to 8 hours using hypothermic machine perfusion in sheep. The Journal of Heart and Lung Transplantation, 42 (8), 1015-1029. doi: 10.1016/j.healun.2023.03.020
Aminu, Abimbola J., Chen, Weixuan, Yin, Zeyuan, Kuniewicz, Marcin, Walocha, Jerzy, Perde, Filip, Molenaar, Peter, Iaizzo, Paul A., Dobrzynski, Halina and Atkinson, Andrew J. (2022). Novel micro-computed tomography contrast agents to visualise the human cardiac conduction system and surrounding structures in hearts from normal, aged, and obese individuals: Iodine and graphene oxide – visualising human conduction system in normal, aged, and obese hearts. Translational Research in Anatomy, 27 100175, 1-17. doi: 10.1016/j.tria.2022.100175
See Hoe, Louise E., Wildi, Karin, Obonyo, Nchafatso G., Bartnikowski, Nicole, McDonald, Charles, Sato, Kei, Heinsar, Silver, Engkilde-Pedersen, Sanne, Diab, Sara, Passmore, Margaret R., Wells, Matthew A., Boon, Ai-Ching, Esguerra, Arlanna, Platts, David G., James, Lynnette, Bouquet, Mahe, Hyslop, Kieran, Shuker, Tristan, Ainola, Carmen, Colombo, Sebastiano M., Wilson, Emily S., Millar, Jonathan E., Malfertheiner, Maximillian V., Reid, Janice D., O’Neill, Hollier, Livingstone, Samantha, Abbate, Gabriella, Sato, Noriko, He, Ting ... Fraser, John F. (2021). A clinically relevant sheep model of orthotopic heart transplantation 24 h after donor brainstem death. Intensive Care Medicine Experimental, 9 (1) 60, 1-24. doi: 10.1186/s40635-021-00425-4
Aminu, Abimbola J., Petkova, Maria, Atkinson, Andrew J., Yanni, Joseph, Morris, Alex D., Simms, Robert T., Chen, Weixuan, Yin, Zeyuan, Kuniewicz, Marcin, Holda, Mateusz K., Kuzmin, Vladislav S., Perde, Filip, Molenaar, Peter and Dobrzynski, Halina (2021). Further insights into the molecular complexity of the human sinus node – The role of ‘novel’ transcription factors and microRNAs. Progress in Biophysics and Molecular Biology, 166, 86-104. doi: 10.1016/j.pbiomolbio.2021.04.008
Wells, Matthew A., See Hoe, Louise E., Molenaar, Peter, Pedersen, Sanne, Obonyo, Nchafatso G., McDonald, Charles I., Mo, Weilan, Bouquet, Mahè, Hyslop, Kieran, Passmore, Margaret R., Bartnikowski, Nicole, Suen, Jacky Y., Peart, Jason N., McGiffin, David C., Fraser, John F. and on behalf of the Dead Heart Project (2021). Compromised right ventricular contractility in an ovine model of heart transplantation following 24 h donor brain stem death. Pharmacological Research, 169 105631, 1-12. doi: 10.1016/j.phrs.2021.105631
Dashwood, Alexander, Cheesman, Elizabeth, Wong, Yee Weng, Haqqani, Haris, Beard, Nicole, Hay, Karen, Spratt, Melanie, Chan, Wandy and Molenaar, Peter (2021). Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline. Pharmacology Research and Perspectives, 9 (3) e00760, e00760. doi: 10.1002/prp2.760
Pineda, Santiago, Nikolova-Krstevski, Vesna, Leimena, Christiana, Atkinson, Andrew J., Altekoester, Ann-Kristin, Cox, Charles D., Jacoby, Arie, Huttner, Inken G., Ju, Yue-Kun, Soka, Magdalena, Ohanian, Monique, Trivedi, Gunjan, Kalvakuri, Sreehari, Birker, Katja, Johnson, Renee, Molenaar, Peter, Kuchar, Dennis, Allen, David G., Van Helden, Dirk F., Harvey, Richard P., Hill, Adam P., Bodmer, Rolf, Vogler, Georg, Dobrzynski, Halina, Ocorr, Karen and Fatkin, Diane (2021). Conserved Role of the Large Conductance Calcium-Activated Potassium Channel, KCa1.1, in Sinus Node Function and Arrhythmia Risk. Circulation: Genomic and Precision Medicine, 14 (2) 003144, 230-242. doi: 10.1161/CIRCGEN.120.003144
Dashwood, Alexander, Beard, Nicole, Wong, Yee Weng, Haqqani, Haris, Cheesman, Elizabeth and Molenaar, Peter (2020). Correction to “Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure”. ACS Pharmacology and Translational Science, 3 (6), 1422-1422. doi: 10.1021/acsptsci.0c00148
Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure?
Denniss, Amanda L., Dashwood, Alexander M., Molenaar, Peter and Beard, Nicole A. (2020). Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure?. Biophysical Reviews, 12 (4), 865-878. doi: 10.1007/s12551-020-00736-y
Dashwood, Alexander, Cheesman, Elizabeth, Beard, Nicole, Haqqani, Haris, Wong, Yee Weng and Molenaar, Peter (2020). Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure. ACS Pharmacology and Translational Science, 3 (4) acsptsci.0c00003, 563-582. doi: 10.1021/acsptsci.0c00003
Ashna, A., van Heiden, D. F., dos Remedios, C., Molenaar, P. and Laver, D. R. (2020). Phenytoin reduces activity of cardiac ryanodine receptor 2; a potential mechanism for its cardioprotective action. Molecular Pharmacology, 97 (4), 250-258. doi: 10.1124/mol.119.117721
Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814
Walweel, Kafa, Gomez-Hurtado, Nieves, Rebbeck, Robyn T., Oo, Ye Wint, Beard, Nicole A., Molenaar, Peter, dos Remedios, Cris, van Helden, Dirk F., Cornea, Razvan L., Knollmann, Björn C. and Laver, Derek R. (2019). Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814. Journal of Molecular and Cellular Cardiology, 130, 96-106. doi: 10.1016/j.yjmcc.2019.03.018
Mo, Weilan, Michel, Martin C., Lee, Xiang Wen, Kaumann, Alberto J. and Molenaar, Peter (2017). The β3-adrenoceptor agonist mirabegron increases human atrial force through β1-adrenoceptors: an indirect mechanism?. British Journal of Pharmacology, 174 (16), 2706-2715. doi: 10.1111/bph.13897
Walweel, K., Molenaar, P., Imtiaz, M. S., Denniss, A., dos Remedios, C., van Helden, D. F., Dulhunty, A. F., Laver, D. R. and Beard, N. A. (2017). Ryanodine receptor modification and regulation by intracellular Ca2+ and Mg2+ in healthy and failing human hearts. Journal of Molecular and Cellular Cardiology, 104, 53-62. doi: 10.1016/j.yjmcc.2017.01.016
Foster, Simon R., Porrello, Enzo R., Stefani, Maurizio, Smith, Nicola J., Molenaar, Peter, Dos Remedios, Cristobal G., Thomas, Walter G. and Ramialison, Mirana (2015). Cardiac gene expression data and in silico analysis provide novel insights into human and mouse taste receptor gene regulation. Naunyn-Schmiedeberg's Archives of Pharmacology, 388 (10) 1118, 1009-1027. doi: 10.1007/s00210-015-1118-1
G protein-coupled receptors in cardiac biology: old and new receptors
Foster, Simon R, Roura, Eugeni, Molenaar, Peter and Thomas, Walter G. (2015). G protein-coupled receptors in cardiac biology: old and new receptors. Biophysical Reviews, 7 (1), 77-89. doi: 10.1007/s12551-014-0154-2
Walweel, Kafa, Li, Jiao, Molenaar, Peter, Imtiaz, Mohammad S., Quail, Anthony, dos Remedios, Cris G., Beard, Nicole A., Dulhunty, Angela F., van Helden, Dirk F. and Laver, Derek R. (2014). Differences in the regulation of RyR2 from human, sheep, and rat by Ca2+ and Mg2+ in the cytoplasm and in the lumen of the sarcoplasmic reticulum. Journal of General Physiology, 144 (3), 263-271. doi: 10.1085/jgp.201311157
Molenaar, Peter, Christ, Torsten, Berk, Emanuel, Engel, Andreas, Gillette, Katherine T., Galindo-Tovar, Alejandro, Ravens, Ursula and Kaumann, Alberto J. (2014). Carvedilol induces greater control of β2- than β1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium. Naunyn-Schmiedeberg's Archives of Pharmacology, 387 (7), 629-640. doi: 10.1007/s00210-014-0974-4
Kiriazis, Helen, Tugiono, Niquita, Xu, Qi, Gao, Xiao-Ming, Jennings, Nicole L., Ming, Ziqui, Su, Yidan, Klenowski, Paul, Summers, Roger J., Kaumann, Alberto, Molenaar, Peter and Du, Xiao-Jun (2013). Chronic activation of the low affinity site of beta(1)-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling. British Journal of Pharmacology, 170 (2), 352-365. doi: 10.1111/bph.12272
Molenaar, Peter, Christ, Torsten, Hussain, Rizwan I., Engel, Andreas, Berk, Emanuel, Gillette, Katherine T., Chen, Lu, Galindo-Tovar, Alejandro, Krobert, Kurt A., Ravens, Ursula, Levy, Finn Olav and Kaumann, Alberto J. (2013). PDE3, but not PDE4, reduces beta 1- and beta 2-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients. British Journal of Pharmacology, 169 (3), 528-538. doi: 10.1111/bph.12167
Expression, Regulation and Putative Nutrient-Sensing Function of Taste GPCRs in the Heart
Foster, Simon R., Porrello, Enzo R., Purdue, Brooke, Chan, Hsiu-Wen, Voigt, Anja, Frenzel, Sabine, Hannan, Ross D., Moritz, Karen M., Simmons, David G., Molenaar, Peter, Roura, Eugeni, Boehm, Ulrich, Meyerhof, Wolfgang and Thomas, Walter G. (2013). Expression, Regulation and Putative Nutrient-Sensing Function of Taste GPCRs in the Heart. PLoS ONE, 8 (5) e64579, e64579-1-e64579-10. doi: 10.1371/journal.pone.0064579
Chandler, Natalie, Aslanidi, Oleg, Buckley, David, Inada, Shin, Birchall, Steven, Atkinson, Andrew, Kirk, Danielle, Monfredi, Oliver, Molenaar, Peter, Anderson, Robert, Sharma, Vinod, Sigg, Daniel, Zhang, Henggui, Boyett, Mark and Dobrzynski, Halina (2011). Computer three-dimensional anatomical reconstruction of the human sinus node and a novel paranodal area. Anatomical Record, 294 (6), 970-979. doi: 10.1002/ar.21379
Molecular architecture of the human specialised atrioventricular conduction axis
Greener, I. D., Monfredi, O., Inada, S., Chandler, N. J, Tellez, J.O., Atkinson, A., Taube, M. A., Billeter, R., Anderson, R. H., Efimov, I. R., Molenaar, P., Sigg, D. C., Sharma, V., Boyett, M. R. and Dobrzynski, H. (2011). Molecular architecture of the human specialised atrioventricular conduction axis. Journal of Molecular and Cellular Cardiology, 50 (4), 642-651. doi: 10.1016/j.yjmcc.2010.12.017
Christ, Torsten, Molenaar, Peter, Klenowski, Paul M., Ravens, Ursula and Kaumann, Alberto J. (2011). Human atrial β 1L-adrenoceptor but not β 3- adrenoceptor activation increases force and Ca 2+ current at physiological temperature. British Journal of Pharmacology, 162 (4), 823-839. doi: 10.1111/j.1476-5381.2010.00996.x
P2 purinergic receptor mRNA in rat and human sinoatrial node and other heart regions
Musa, Hanny, Tellez, James O., Chandler, Natalie J., Greener, Ian D., Maczewski, Michał, Mackiewicz, Urszula, Beresewicz, Andrzej, Molenaar, Peter, Boyett, Mark R. and Dobrzynski, Halina (2009). P2 purinergic receptor mRNA in rat and human sinoatrial node and other heart regions. Naunyn-Schmiedeberg's Archives of Pharmacology, 379 (6), 541-549. doi: 10.1007/s00210-009-0403-2
Molecular Architecture of the Human Sinus Node Insights Into the Function of the Cardiac Pacemaker
Chandler, Natalie J., Greener, Ian D., Tellez, James O., Inada, Shin, Musa, Hanny, Molenaar, Peter, DiFrancesco, Dario, Baruscotti, Mirko, Longhi, Renato, Anderson, Robert H., Billeter, Rudolf, Sharma, Vinod, Sigg, Daniel C., Boyett, Mark R. and Dobrzynski, Halina (2009). Molecular Architecture of the Human Sinus Node Insights Into the Function of the Cardiac Pacemaker. Circulation, 119 (12), 1562-1575. doi: 10.1161/CIRCULATIONAHA.108.804369
The low-affinity site of the β1-adrenoceptor and its relevance to cardiovascular pharmacology
Kaumann, Alberto J. and Molenaar, Peter (2008). The low-affinity site of the β1-adrenoceptor and its relevance to cardiovascular pharmacology. Pharmacology and Therapeutics, 118 (3), 303-336. doi: 10.1016/j.pharmthera.2008.03.009
Cheng lu, Meyers, Deborah, Javorsky, George, Bursto, Darryl, Lolekha, Pakorn, Lucas, Margaret, Semmler, Annalese B. T., Savarimuthu, Santiyagu M., Fong, Kwun M., Yang, Ian A., Atherton, John, Galbraith, Andrew J., Parsonage, William A. and Molenaar, Peter (2007). Arg389Gly-beta(1)-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol. Pharmacogenetics And Genomics, 17 (11), 941-949. doi: 10.1097/FPC.0b013e3282ef7354
Molenaar, P., Chen, L., Semmler, A. B. T., Parsonage, W. A. and Kaumann, A. J. (2007). Human heart beta-adrenoceptors: beta(1)-adrenoceptor diversification through 'affinity states' and polymorphism. Clinical And Experimental Pharmacology And Physiology, 34 (10), 1020-1028. doi: 10.1111/j.1440-1681.2007.04730.x
beta(2)-adrenoceptor polymorphisms and obstructive airway diseases: Important issues of study design
Yang, Ian A., Ng, Taria, Molenaar, Peter and Fong, Kwun M. (2007). beta(2)-adrenoceptor polymorphisms and obstructive airway diseases: Important issues of study design. Clinical And Experimental Pharmacology and Physiology, 34 (10), 1029-1036. doi: 10.1111/j.1440-1681.2007.04731.x
Kaumann, Alberto, Semmler, Annalese B. T. and Molenaar, Peter (2007). The effects of both noradrenaline and CGP12177, mediated through human beta(1)-adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells. Naunyn-schmiedebergs Archives of Pharmacology, 375 (2), 123-131. doi: 10.1007/s00210-007-0140-3
Molenaar, P., Savarimuthu, S. M., Sarsero, D., Chen, L., Semmler, A. B. T., Carle, A., Yang, I., Bartel, S., Vetter, D., Beyerdorfer, I., Krause,E-G. and Kaumann, A. J. (2007). (-)Adrenaline elicits positive inotropic,lusitropic, and biochemical effects through ß2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consisten with Gs coupling but not with Gi coupling.. Naunyn-Schmiedeberg's Archives of Pharmocolgy, 375 (1), 11-28. doi: 10.1007/s00210-007-0138-x
Molenaar, Peter, Chen, Lu and Parsonage, William A. (2006). Cardiac implications for the use of beta(2)-adrenoceptor agonists for the management of muscle wasting. British Journal of Pharmacology, 147 (6), 583-586. doi: 10.1038/sj.bjp.0706670
Carvedilol blocks beta(2)- more than beta(1)-adrenoceptors in human heart
Molenaar, Peter, Christ, Torsten, Ravens, Ursula and Kaumann, Alberto (2006). Carvedilol blocks beta(2)- more than beta(1)-adrenoceptors in human heart. Cardiovascular Research, 69 (1), 128-139. doi: 10.1016/j.cardiores.2005.08.024
Li, J., Wang, J. C., Russell, F. D. and Molenaar, P. (2005). Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II. British Journal of Pharmacology, 145 (4), 432-440. doi: 10.1038/sj.bjp.0706217
Winkel, KD, Tibballs, J, Molenaar, P, Lambert, G, Coles, P, Ross-Smith, M, Wiltshire, C, Fenner, PJ, Gershwin, LA, Hawdon, GM, Wright, CE and Angus, JA (2005). Cardiovascular actions of the venom from the Irukandji (Carukia barnesi) jellyfish: Effects in human, rat and guinea-pig tissues in vitro and in pigs in vivo. Clinical And Experimental Pharmacology And Physiology, 32 (9), 777-788. doi: 10.1111/j.1440-1681.2005.04258.x
Fundamental considerations of beta-adrenoceptor subtypes in human heart failure
Molenaar, P and Parsonage, WA (2005). Fundamental considerations of beta-adrenoceptor subtypes in human heart failure. Trends In Pharmacological Sciences, 26 (7), 368-375. doi: 10.1016/j.tips.2005.05.005
Cardiovascular actions of human urotensin II - considerations for hypertension
Russell, F. D. and Molenaar, P. (2004). Cardiovascular actions of human urotensin II - considerations for hypertension. Naunyn-Schmiedebergs Archives of Pharmacology, 369 (3), 271-273. doi: 10.1007/s00210-004-0876-y
Brattelid, T, Qvigstad, E, Lynham, JA, Molenaar, P, Aass, H, Geiran, O, Skomedal, T, Osnes, JB, Levy, FO and Kaumann, AJ (2004). Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure. Naunyn-Schmiedeberg's Arch Pharmacol, 370 (3), 157-166. doi: 10.1007/s00210-004-0963-0
Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart
Russell, FD and Molenaar, P (2004). Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart. Cardiovascular Research, 63 (4), 673-681. doi: 10.1016/j.cardiores.2004.05.009
Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro
Russell, F. D., Kearns, P., Toth, I. and Molenaar, P. (2004). Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro. Journal of Pharmacology And Experimental Therapeutics, 310 (1), 209-214. doi: 10.1124/jpet.104.065425
Joseph, Shirin S., Lynham, James A., Molenaar, Peter, Grace, Andrew A., Colledge, William H. and Kaumann, Alberto J. (2003). Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta(1)-adrenoceptor in human atrium and recombinant receptors. Naunyn-Schmiedeberg's Archives of Pharmacology, 368 (6), 496-503. doi: 10.1007/s00210-003-0835-z
Sarsero, Doreen, Russell, Fraser D., Lynham, James A., Rabnott, Glenn, Yang, Ian, Fong, Kwun M., Li, Li, Kaumann, Alberto J. and Molenaar, Peter (2003). (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta1-adrenoceptor. Naunyn-Schmiedeberg's Archives of Pharmacology, 367 (1), 10-21. doi: 10.1007/s00210-002-0652-9
Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure
Russell, F. D., Meyers, D. E., Galbraith, A., Bett, N., Toth, I., Kearns, P. S. and Molenaar, P. (2003). Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. American Journal of Physiology - Heart & Circulatory Physiology, 285 (Oct.2003), H1576-H1581. doi: 10.1152/ajpheart.00217.2003
The 'state' of beta-adrenoceptors
Molenaar, P. (2003). The 'state' of beta-adrenoceptors. British Journal of Pharmacology, 140 (1), 1-2. doi: 10.1038/sj.bjp.0705420
(-)-Pindolol acts through two states of the beta(1)-adrenoceptor in human atrium and CHO cells.
Kaumann, AJ, Lynham, JA, Joseph, SS, Colledge, WH, Grace, AA and Molenaar, P (2002). (-)-Pindolol acts through two states of the beta(1)-adrenoceptor in human atrium and CHO cells.. British Journal of Pharmacology, 135
Molenaar, P., Rabnott, G., Yang, I., Fong, K. M., Savarimuthu, S. M., Li, L., West, M. J. and Russell, F. D. (2002). Conservation of the cardiostimulant effects of (-)-Norepinephrine across Ser49Gly and Gly389Arg Beta1-adrenergic receptor polymorphisms in human right atrium in vitro. Journal of The American College of Cardiology, 40 (7), 1275-1282. doi: 10.1016/S0735-1097(02)02137-X
Kaumann, AJ, Engelhardt, S, Hein, L, Molenaar, P and Lohse, M (2001). Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta(1)/beta(2)-adrenoceptor knockout mice. Obligatory role of beta(1)-adrenoceptors for putative beta 4-adrenoceptor pharmacology. Naunyn-schmiedebergs Archives of Pharmacology, 363 (1), 87-93. doi: 10.1007/s002100000336
Cardiostimulant effects of urotensin-II in human heart in vitro
Russell, FD, Molenaar, P and O'Brien, DM (2001). Cardiostimulant effects of urotensin-II in human heart in vitro. British Journal of Pharmacology, 132 (1), 5-9. doi: 10.1038/sj.bjp.0703811
Heubach, J. F., Graf, E. M., Molenaar, P., Jager, A., Schroder, F., Herzig, S., Harding, S. E. and Ravens, U. (2001). Murine ventricular L-type Ca2+ current is enhanced by zinterol via beta(1)-adrenoceptors, and is reduced in TG4 mice overexpressing the human beta(2)-adrenoceptor. British Journal of Pharmacology, 133 (1), 73-82. doi: 10.1038/sj.bjp.0704045
Molenaar, P., Bartel, S., Cochrane, A., Vetter, D., Jalali, H., Pohlner, P., Burrell, K., Karczewski, P, Krause, E. and Kaumann, A. J. (2000). Both beta(2)- and beta(1)-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of fallot infants, consistent with selective coupling of beta(2)-adrenergic receptors to G(s)-protein. Circulation, 102 (15), 1814-1821. doi: 10.1161/01.CIR.102.15.1814
Oostendorp, J., Preitner, F., Moffatt, J., Jimenez, M., Giacobino, J. P., Molenaar, P. and Kaumann, A. J. (2000). Contribution of beta-adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wild-type and beta(3)-adrenoceptor knockout mice. British Journal of Pharmacology, 130 (4), 747-758. doi: 10.1038/sj.bjp.0703365
Burrell, K. M., Molenaar, P., Dawson, P. J. and Kaumann, A. J. (2000). Contractile and arrhythmic effects of endothelin receptor agonists in human heart in vitro: Blockade with SB 209670. Journal of Pharmacology and Experimental Therapeutics, 292 (1), 449-459.
Angus, J, Sarsero, D, Fujiwara, T, Molenaar, P and Xi, Q (2000). Quantitative analysis of vascular to cardiac selectivity of L- and T-type voltage-operated calcium channel antagonists in human tissues. Clinical And Experimental Pharmacology And Physiology, 27 (12), 1019-1021. doi: 10.1046/j.1440-1681.2000.03369.x
The human heart endothelin system: ET-1 synthesis, storage, release and effect
Russell, F. D. and Molenaar, P. (2000). The human heart endothelin system: ET-1 synthesis, storage, release and effect. Trends in Pharmacological Sciences, 21 (9), 353-359. doi: 10.1016/S0165-6147(00)01524-8
Kaumann, A, Bartel, S, Molenaar, P, Sanders, L, Burrell, K, Vetter, D, Hempel, P, Karczewski, P and Krause, EG (1999). Activation of beta(2)-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure. Circulation, 99 (1), 65-72.
Sarsero, D., Molenaar, P., Kaumann, A. J. and Freestone, N. S. (1999). Putative beta(4)-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[H-3]-CGP 12177 binding. British Journal of Pharmacology, 128 (7), 1445-1460. doi: 10.1038/sj.bjp.0702936
Arch, JRS, Kaumann, AJ, Molenaar, P, Sennitt, MV, Berge, JM, Chapman, H and Kelly, J (1999). Studies on a novel selective beta(3)-adrenoceptor agonist in human right atrial appendage and human white adipocytes. British Journal of Pharmacology, 126, U55-U55.
Sarsero, Doreen, Molenaar, Peter and Kaumann, Alberto J. (1998). Validity of (-)-[H-3]-CGP 12177A as a radioligand for the 'putative beta(4)-adrenoceptor' in rat atrium. British Journal of Pharmacology, 123 (3), 371-380. doi: 10.1038/sj.bjp.0701609
Kaumann, AJ, Preitner, F, Sarsero, D, Molenaar, P, Revelli, JP and Giacobino, JP (1998). (-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta(4)-adrenoceptors in both wild-type and beta(3)-adrenoceptor knockout mice. Molecular Pharmacology, 53 (4), 670-675.
Sarsero, D, Molenaar, P and Kaumann, AJ (1998). (-)-[H-3]-CGP 12177 radiolabels beta(1)-, beta(2)- and putative beta(4)-adrenoceptors in human atrium and ventricle.. Naunyn-schmiedebergs Archives of Pharmacology, 358 (1), R629-R629.
Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists
Sarsero, D, Fujiwara, T, Molenaar, P and Angus, JA (1998). Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists. British Journal of Pharmacology, 125 (1), 109-119. doi: 10.1038/sj.bjp.0702045
Burrell, KM, Molenaar, P and Kaumann, AJ (1998). Inotropic and arrhythmic effects of endothelin receptor agonists in human heart: Possible involvement of multiple receptors, L-type calcium channels and Gi-protein.. Naunyn-schmiedebergs Archives of Pharmacology, 358 (1), R627-R627.
Molenaar, P (1998). The contribution of classical (beta(1/2)-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta(3)-adrenoceptor agonists of differing selectivities. Journal of Pharmacology And Experimental Therapeutics, 285 (3), 1084-1095.
Molenaar, P, Sarsero, D, Lynham, JA and Kaumann, AJ (1998). The putative beta(4)-adrenoceptor activates the cyclic AMP pathway in human heart: Inhibition of positive inotropic responses by adenosine and carbachol. Naunyn-schmiedebergs Archives of Pharmacology, 358 (1), R629-R629.
Molenaar, P, Sarsero, D, Arch, JRS, Kelly, J, Henson, SM and Kaumann, AJ (1997). Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta(3)-adrenoceptor and rodent intestinal beta(3)-adrenoceptors. British Journal of Pharmacology, 120 (2), 165-176. doi: 10.1038/sj.bjp.0700850
Modulation of human cardiac function through 4 beta-adrenoceptor populations
Kaumann, AJ and Molenaar, P (1997). Modulation of human cardiac function through 4 beta-adrenoceptor populations. Naunyn-schmiedebergs Archives of Pharmacology, 355 (6), 667-681. doi: 10.1007/PL00004999
On criteria for functional beta(3)-adrenoceptors
Molenaar, P and Kaumann, AJ (1997). On criteria for functional beta(3)-adrenoceptors. Trends In Pharmacological Sciences, 18 (7), 258-258. doi: 10.1016/S0165-6147(97)90635-0
Molenaar, P, Sarsero, D and Kaumann, AJ (1997). Proposal for the interaction of non-conventional partial agonists and catecholamines with the 'putative beta(4)-adrenoceptor' in mammalian heart. Clinical And Experimental Pharmacology And Physiology, 24 (9-10), 647-656. doi: 10.1111/j.1440-1681.1997.tb02107.x
Kaumann, AJ, Lynham, JA, Sarsero, D and Molenaar, P (1997). The atypical cardiostimulant beta-adrenoceptor is distinct from beta-adrenoceptors and coupled to a cyclic AMP-dependent pathway in human and rat myocardium. British Journal of Pharmacology, 120, P102-P102.
Spratt, M., Dashwood, A., Cheesman, E., Haqqani, H., Wong, Y., Chan, W., Laver, D. and Molenaar, P. (2022). Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing Ventricle. 70th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Gold Coast, QLD Australia, 11-14 August 2022. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2022.06.062
See Hoe, L., Bouquet, M., Hyslop, K., Passmore, M., Wells, M., Sato, K., Wilson, E., Wildi, K., Skeggs, K., Palmeri, C., Reid, J., O'Neill, H., Bartnikowski, N., Jung, J., Ainola, C., Abbate, G., Colombo, S., Obonyo, N., McDonald, C., Shuker, T., Heinsar, S., Haymet, A., Engkilde-Pedersen, S., Peart, J., Molenaar, P., Li Bassi, G., Suen, J., McGiffin, D. and Fraser, J. (2022). Post-transplant cardiac contractility and mitochondrial function is preserved following 8 hours hypothermic ex vivo perfusion in sheep. 70th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Gold Coast, QLD, Australia, 11-14 August 2022. Chatswood, NSW, Australia: Elsevier. doi: 10.1016/j.hlc.2022.06.547
Development of an ovine model of heart transplantation following 24-hour brain stem death
See Hoe, L., Engkilde-Pedersen, S., Obonyo, N., Wells, M., Boon, C., Bartnikowski, N., Passmore, M., McDonald, C., Black, D., Molenaar, P., Diab, S., Suen, J., Marasco, S., McGiffin, D. and Fraser, J. (2018). Development of an ovine model of heart transplantation following 24-hour brain stem death. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, Australia, 2-5 August 2018. Chatswood, NSW, Australia: Elsevier . doi: 10.1016/j.hlc.2018.06.111
Foster, Simon R., Porrello, Enzo R., Stefani, Maurizio, Smith, Nicola J., Molenaar, Peter, dos Remedios, Cris G., Thomas, Walter G. and Ramialison, Mirana (2015). Transcriptional Regulation of Taste Receptor Genes: Novel Insights From In Silico and Cardiac Gene Expression Analyses. 15th Scientific Meeting of the Australasian Association for ChemoSensory Science (AACSS), Brisbane, QLD Australia, 03-05 December 2014. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/chemse/bjv008
The role of beta1 adrenoceptors in the development of alcohol dependence
Klenowski, P. M., Holgate, J., Bellingham, M., Molenaar, P. and Bartlett, S. (2013). The role of beta1 adrenoceptors in the development of alcohol dependence. Neuroscience 2013: 43rd Annual Meeting of the Society for Neuroscience, San Diego, CA, USA, 9-13 November, 2013.
Chen, L., Meyers, D., Semmler, A.B., Yang, I., Pakorn, L., Lucas, M., Jovarsky, G., Savarimuthu, S., Galbraith, A., Parsonage, W. and Molenaar, P. (2006). Beta1-adrenoceptor (AR) Arg389Gly polymorphisms affect responses to carvedilol in patients with idiopathic dilated cardiomyopathy. 15th World Congress of Pharmacology, Beijing, China, 2nd - 7th July, 2006. China: Chinese Pharmacological Society.
Molenaar, P., Chen, Lu, Meyers, E., Javorsky, G., Burstow, M., Lucas, P., Lolekha, J., Atherton, A., Semmler, A. B., Savarimuthu, S., Fong, K. M., Yang, I. A., Galbraith, A. and Parsonage, W. A. (2006). Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors. The Australian Health and Medical Research Congress, Melbourn, Australia, 26th November - 1st December, 2006. Australia: Australian Govenment NHMRC.
Christ, T., Molenaar, P., Galindo-Tovar, A., Ravens, U. and Kaumann, A. J. (2006). Contractile responses through Gs-coupled receptors are reduced by phosphodiesterase3 activity in human isolated myocardium. Compartmentalization of cyclic AMP signalling, Cambridge, U.K., 29-30 March, 2006.
Molenaar, P., Chen, Lu, Semmler, A. B., Parsonage, W. A. and Kaumann, A. (2006). Human heart Beta-adrenoceptors:-Beta1-adrenoceptor diversification through 'affinity states' and polymorphism. The Australian Health & Medical Research Congress, Melbourne, Australia, 26 November - 1 December, 2006. Australia: Australian Govenment NHMRC.
Molenaar, P., Chen, L., Semmler, A. B., Parsonage, W. A. and Kaumann, A. (2006). Human heart beta1-adrenoceptor heterogeneity - diversification through 'affinity states' and polymorphism. 15th World Congress of Pharmacology, Beijing, China, 7 - 9 July, 2006. China: Institute of Vascular Medicine.
Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart
Molenaar, P., Christ, T., Ravens, U., Chen, L. and Kaumann, A. (2005). Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart. Joint Meeting of ASCEPT & APSA, Melbourne, Australia, 4 - 7 Dec, 2005. Australia: ASCEPT.
Carvedilol blocks beta2-adrenoceptors more than beta1-adrenoceptors in human atrium
Kaumann, A. J. and Molenaar, P. (2005). Carvedilol blocks beta2-adrenoceptors more than beta1-adrenoceptors in human atrium. BPS Summer Meeting 2005, Cambridge, U.K., July, 2005.
Kaumann, A. J., Christ, T., Ravens, U. and Molenaar, P. (2005). Carvedilol causes greater persistent blockage of beta2- than beta1-adrenoceptors in human failing myocardium. BPS Summer Meeting 2005, Cambridge, U.K., July, 2005.
Qvigstad, E., Brattelid, T., Sjaastad, I., Molenaar, P., Birkeland, J. A., Andressen, K. W., Krobert, K. A., Sejersted, O. M., Skomedal, T., Osnes, J-B., Kaumann, A. J. and Levy, F. O. (2005). Rationale for treatment of heart failure by blockade of ventricular serotonin receptors appearing in heart failure. International Soc for Heart Research, European Section Mtg, Norway, 21-25 Jun, 2005. Italy: Medimond International.
Li, J., Wang, J., Russell, F. D. and Molenaar, P. (2004). Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin. 2004 ISHR World Congress Meeting, Brisbane, Qld, Australia, 7-11 Aug, 2004. United Kingdom: Academic Press.
Krause, E.-G., Bartel, S., Vetter, D., Karczewski, P., Russell, F. D., Kaumann, A. J. and Molenaar, P. (2004). Both 1- and 2-adrenoceptors mediate increases in contractile force and hastening of relaxation in human atrium. 2004 ISHR World Congress Meeting, Brisbane, Qld, Australia, 7 - 11 August, 2004. United Kingdom: Academic Press. doi: 10.1016/j.yjmcc.2004.05.003
Investigation of urotensin-II converting enzyme activity in human cells and blood
Kearns, P., Russell, F. D., Toth, I. and Molenaar, P. (2004). Investigation of urotensin-II converting enzyme activity in human cells and blood. 8th Annual Scientific Sessions of the Latin American Section of the International-Society for Heart Research, Brisbane, Qld, Australia, 7th - 11th August, 2004. United Kingdom: Academic Press. doi: 10.1016/j.yjmcc.2004.05.003
Russell, F. D. and Molenaar, P. (2004). Regulatory myosin light chain signaling pathways in urotensin-II-mediated positive inotropic effect in human right atrium. 2004 ISHR World Congress Meeting, Brisbane, Qld, Australia, 7 - 11 August, 2004. London, England: Academic Press. doi: 10.1016/j.yjmcc.2004.05.003
Activation of calcineurin in explanted human ventricle by endogenous peptides
Li, J., Russell, F. D. and Molenaar, P. (2003). Activation of calcineurin in explanted human ventricle by endogenous peptides. ASCEPT, Sydney, 30 Nov - 3 Dec, 2003. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.
Molenaar, P. and Kaumann, A. J. (2003). Intrinsic sympathomimetic activity (ISA) of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human right atrium. ASCEPT, Sydney, 30 Nov - 3 Dec, 2003. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.
Russell, F. D. and Molenaar, P. (2003). Regulatory myosin light chain signaling pathways in urotensin-II-mediated positive inotropic effect in human right atrium. ASCEPT, Sydney, 30 Nov - 3 Dec, 2003. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.
Molenaar, P., Russell, F. D., Rabnott, G., Yang, I., Fong, K. M., Savarimuthu, S. M., Li, L. and West, M. J. (2002). The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atrium. American Heart Association Scientific Sessions 2002, Chicago, 17-20 Nov, 2002. Hagerstown, U.S.A.: Lippincott Williams & Wilkins.
Kaumann, A. J., Engelhardt, S., Molenaar, P. and Lohse, M. (2000). (-)-CGP 12177-evoked cardiostimulation is abolished in double b1-/b2-adrenoceptor (AR) knockout mice.. Joint Meeting of ASCEPT and the British Pharmacological Society, Newcastle, Australia, 03-06 Dec, 2000. Sydney: Aust Society of Clin and Exp Pharmacologists and Toxicologists.
Cardiostimulant effects of human urotensin-II in human heart.
Russell, F. D., Molenaar, P. and O'Brien, D. M. (2000). Cardiostimulant effects of human urotensin-II in human heart.. Joint Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and the British Pharmacological Society, Newcastle, Australia, 03-06 Dec, 2000. Sydney: Aust Society of Clin & Exp Pharmacologists & Toxicologists.
Endogenous modulators of human heart contractility
Molenaar, P., Russell, F. D. and Burrell, K. (2000). Endogenous modulators of human heart contractility. ISHR Melbourne Conference 2000: Benchtop Bedside the Beside, Melbourne, Australia, 05-09 Aug, 2000. Melbourne: International Society for Heart Research (Australasian Section).
Molenaar, P. and Kaumann, A. J. (2000). b1-, b2- and putative b4-adrenoceptors (AR) in adult and infant human heart: selective coupling of b2-AR to Gs-protein.. Joint Meeting of ASCEPT and the British Pharmacological Society, Newcastle, Australia, 03-06 Dec, 2000. Sydney: Aust Society of Clin. and Exp. Pharmacologists & Toxicologists.
Molenaar, P., Oostendorp, J., Preitner, F., Moffat, J., Jimenez, M., Giacobino, J. P. and Kaumann, A. J. (1999). Contribution of b-adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wild-type and b3-adrenoceptor knockout mice: Involvement of the putative b4-adrenoceptor. 33rd Annual Scientific Meeting of ASCEPT, Sydney Convention & Exhibition Cen., Darling Harbour, 4 - 8 Dec, 1999. Sydney: Aust. Soc. of Clinical & Experimental Pharm. & Toxicol..
Proceedings of the Australian Society for Medical Research
P. Molenaar, F. D. Russell, G. C. Rabnott, I. Yang, K. M. Fong and M. J. West eds. (2001). Proceedings of the Australian Society for Medical Research. BioInnovation: The Future of Medical Research, Gold Coast, Queensland, Australia, 24 - 27 November, 2001. Australia: Australian Society for Medical Research.
(2023–2028) Research Donation Generic
(2023–2026) Prince Charles Hospital Foundation
Determination of effects of Atrogi compounds in human heart
(2022–2023) Atrogi AB
(2021–2023) Prince Charles Hospital Foundation
Assessment of effects of Atrogi future medicines in human heart
(2020–2021) Atrogi AB
(2020–2021) National Heart Foundation Vanguard Grant
New Medicines to Keep Heart Failure Patients Alive
(2019–2024) Prince Charles Hospital Foundation
Cardio-Vascular Molecular & Translational Research Group
(2018–2023) Prince Charles Hospital Foundation
Identifying cyclic AMP limiting phosphodiesterases for heart failure treatment
(2016–2020) Prince Charles Hospital Foundation
(2015–2018) Prince Charles Hospital Foundation
Phosphodiesterase 2, 3 and 4 control of arrhythmias in the human heart
(2014–2017) Prince Charles Hospital Foundation
Phosphodiesterase enzyme control of arrhythmias in human heart
(2013) Prince Charles Hospital Foundation
Defining role of B2-adrenoceptors and human ventricular arrhythmias
(2012–2014) Prince Charles Hospital Foundation
To determine the effects of (-)- and (±)-ASL-8052 in the human heart (in vitro)
(2011–2013) UniQuest Pty Ltd
Molecular attributes and physiological significance of beta1L-adrenoceptors
(2008–2010) NHMRC Project Grant
Elucidation of the molecular requirements of the low affinity 'state' of the beta1-adrenoceptor
(2005–2007) NHMRC Project Grant
The genetic basis of B-blockers in heart failure
(2005–2006) Prince Charles Hospital Foundation
NHMRC Senior Research Fellowship -- Grant In Aid for Year 7
(2004–2005) NHMRC Fellowship Grant
Adrenergic receptor regulation of calcineurin in the infant human heart
(2003–2004) Prince Charles Hospital Foundation
(2002–2004) NHMRC Project Grant
Polymorphisms of B1 and B2 adrenoceptors in human heart
(2000–2001) National Heart Foundation of Australia
Effects of chronic administration of B-blockers in contractile function in human heart
(1999–2000) Prince Charles Hospital Foundation
Chronic administration of B-adrenoceptor blockers in end-stage heart failure: Mechanism of benefit
(1999) UQ New Staff Research Start-Up Fund
Localization and quantitation of novel receptors in human heart
(1999) Ramaciotti Foundation
NHMRC RESEARCH FELLOWSHIP (Senior Research Fellow)
(1998–2004) NHMRC Fellowship Grant
Modulation of human cardiac function by B-adrenoceptor and endothelin receptor systems
(1998–2002) NHMRC Project Grant - 5 Yr Extended with Fellow
Cause and prevention of stress induced arrhythmias in human heart
Doctor Philosophy — Principal Advisor
Other advisors:
The Genetic Basis of Carvedilol Responsiveness in Human Heart Failure
(2008) Master Philosophy — Principal Advisor
Other advisors:
FACTORS CONTRIBUTING TO THE DEVELOPMENT OF CARDIAC HYPERTROPHY - CALCINEURIN DEPENDENT PATHWAY
(2006) Doctor Philosophy — Associate Advisor
THE DEVELOPMENT OF A GENE TRANSFER APPROACH FOR THE TREATMENT OF HYPERTENSION.
(2005) Doctor Philosophy — Associate Advisor